FLNA:BMV
Filana Therapeutics Inc
MX$15.92
0.00%
(0.00) एक दिन
5 अक्टू॰, 12:05:31 pm GMT-6 · MXN
search
सभी चिह्न
| सिंबल | कीमत | बदलाव | प्रतिशत में बदलाव |
|---|
insights_autoFLNA के लिए सबसे अहम जानकारी जनरेट की जा रही है...
मार्केट कैपिटलाइज़ेशन
3.40 क॰
औसत वॉल्यूम
0.00
वॉल्यूम
0.00
52 हफ़्तों में सबसे ज़्यादा कीमत
MX$56.00
52 हफ़्तों में सबसे कम कीमत
MX$15.92
कर्मचारियाें की संख्या
19
मार्केट कैपिटलाइज़ेशन
3.40 क॰
औसत वॉल्यूम
0.00
वॉल्यूम
0.00
52 हफ़्तों में सबसे ज़्यादा कीमत
MX$56.00
52 हफ़्तों में सबसे कम कीमत
MX$15.92
कर्मचारियाें की संख्या
19
खबरें
वेब सोर्स और न्यूज़ पार्टनरों से मिली जानकारी
Vietnam.vn
·
1 दिन पहले
एसएंडपी 500 में जून 2026 के बाद से सबसे तेज साप्ताहिक गिरावट दर्ज की गई।
Yahoo Finance
·
1 घंटे पहले
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
MarketWatch
·
10 मिनट पहले
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Simply Wall Street
·
17 मिनट पहले
What Diamondback Energy Holders Bought Into
प्रोफ़ाइल
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Filana Therapeutics Inc के बारे में
सीईओ-
कर्मचारी19
स्थापना की तारीख1998
हेडक्वार्टरऑस्टिन, टेक्सास, यूनाइटेड स्टेट्स
सेक्टर-
वेबसाइटpaintrials.com